Investors are on the edges of their seats, hoping that Quaker Chemical
What analysts say:
- Buy, sell, or hold?: Analysts are very bullish on this stock, unanimously backing it as a buy.
- Revenue Forecasts: On average, analysts predict $164.6 million in revenue this quarter. That would represent a rise of 21% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.75 per share. Estimates range from $0.71 to $0.82.
What our community says:
CAPS All Stars are solidly behind the stock, with 98.5% granting it an "outperform" rating. The community at large concurs with the All Stars, with 97% assigning it a rating of "outperform." Fools have embraced Quaker Chemical, though the message boards have been quiet lately with only 60 posts in the past 30 days. Quaker Chemical has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.
Management:
Quaker Chemical's profit has risen year over year by an average of 52%. Revenue has gone up for three straight quarters. The company's gross margin shrank by 3.9 percentage points in the last quarter. Revenue rose 24.6%, while cost of sales rose 32.3% to $107.1 million from a year earlier.
Quarter | Q1 | Q4 | Q3 | Q2 |
Gross Margin | 33.0% | 33.7% | 35.6% | 35.7% |
Operating Margin | 8.8% | 8.2% | 6.9% | 9.9% |
Net Margin | 6.6% | 4.9% | 4.6% | 6.7% |
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Quaker Chemical now.